Aspen Aerogels, Inc. (NYSE:ASPN – Get Free Report) SVP Corby C. Whitaker sold 55,159 shares of the company’s stock in a transaction on Monday, May 6th. The shares were sold at an average price of $25.01, for a total value of $1,379,526.59. Following the sale, the senior vice president now owns 131,533 shares of the company’s stock, valued at $3,289,640.33. The transaction was disclosed in a filing with the SEC, which is accessible through the SEC website.
Aspen Aerogels Stock Up 1.4 %
Shares of NYSE:ASPN opened at $26.64 on Thursday. The firm has a market cap of $2.03 billion, a P/E ratio of -60.55 and a beta of 1.97. Aspen Aerogels, Inc. has a 12-month low of $5.32 and a 12-month high of $27.09. The business has a fifty day simple moving average of $17.27 and a 200 day simple moving average of $14.13. The company has a quick ratio of 3.29, a current ratio of 4.01 and a debt-to-equity ratio of 0.24.
Aspen Aerogels (NYSE:ASPN – Get Free Report) last posted its quarterly earnings data on Tuesday, February 13th. The construction company reported ($0.01) EPS for the quarter, topping analysts’ consensus estimates of ($0.12) by $0.11. Aspen Aerogels had a negative return on equity of 6.35% and a negative net margin of 10.73%. The company had revenue of $84.22 million for the quarter, compared to analyst estimates of $83.82 million. During the same period in the previous year, the firm earned ($0.20) earnings per share. Analysts predict that Aspen Aerogels, Inc. will post 0.03 earnings per share for the current year.
Institutional Inflows and Outflows
Analyst Upgrades and Downgrades
Several research firms recently weighed in on ASPN. TheStreet raised shares of Aspen Aerogels from a “d+” rating to a “c-” rating in a research report on Wednesday, March 6th. B. Riley upped their price target on shares of Aspen Aerogels from $24.00 to $30.00 and gave the stock a “buy” rating in a report on Friday, May 3rd. HC Wainwright lifted their price objective on shares of Aspen Aerogels from $20.00 to $25.00 and gave the company a “buy” rating in a research note on Friday, May 3rd. Canaccord Genuity Group upped their target price on Aspen Aerogels from $18.00 to $28.00 and gave the stock a “buy” rating in a research note on Friday, May 3rd. Finally, Piper Sandler lifted their price target on Aspen Aerogels from $20.00 to $29.00 and gave the company an “overweight” rating in a research note on Friday, May 3rd. One investment analyst has rated the stock with a sell rating and six have issued a buy rating to the company. Based on data from MarketBeat, the stock has a consensus rating of “Moderate Buy” and an average target price of $25.17.
Get Our Latest Analysis on Aspen Aerogels
Aspen Aerogels Company Profile
Aspen Aerogels, Inc designs, develops, manufactures, and sells aerogel insulation products primarily for use in the energy infrastructure and sustainable insulation materials markets in the United States, Asia, Canada, Europe, and Latin America. It operates in two segments, Energy Industrial and Thermal Barrier.
Featured Stories
- Five stocks we like better than Aspen Aerogels
- What Are Dividend Challengers?
- No New Highs for Cloudflare in 2024
- How to Use Stock Screeners to Find Stocks
- Electronic Arts Earnings Engaging Players and Building Value
- 5 Top Rated Dividend Stocks to Consider
- 3 Tripe-Digit Growth Mid Cap Stocks to Watch This Quarter
Receive News & Ratings for Aspen Aerogels Daily - Enter your email address below to receive a concise daily summary of the latest news and analysts' ratings for Aspen Aerogels and related companies with MarketBeat.com's FREE daily email newsletter.